NuVasive Profile

Performance

   

Odds of Distress

Check how we calculate scores
Equity ratings for NuVasive are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting July 21, 2019 and ending today October 19, 2019. Click here to learn more.

NuVasive Profile

NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California. NuVasive operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 2600 people. more
NuVasive Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
NuVasive SEC Filings
NuVasive SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameNuVasive
CEO, DirectorChristopher BarryView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Medical Devices
InstrumentUSA Stock View All
RegionNorth America
LocationCalifornia U.S.A
Business Address7475 Lusk Boulevard, San Diego, CA 92121, United States
ExchangeBATS Exchange
CIK Number0001142596
CUSIP670704105
SectorHealthcare
IndustryMedical Devices
BenchmarkDOW
Websitewww.nuvasive.com
Phone800 475 9134
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestSeptember 30, 2019
NuVasive (NUVA) is traded on BATS Exchange in USA. It is located in 7475 Lusk Boulevard, San Diego, CA 92121, United States and employs 2,600 people. NuVasive is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with current market capitalization of 3.39 B. NuVasive conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 52.05 M outstanding shares of which 4.12 M shares are now shorted by private and institutional investors with about 8.63 trading days to cover. NUVASIVE currently holds about 128.38 M in cash with 84.84 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.47.
Check NuVasive Probability Of Bankruptcy

Ownership Allocation (%)

NuVasive Target Price Odds Analysis

Odds Below 63.7HorizonTargetOdds Above 63.7
48.57%30 days 63.70 51.13%
Based on normal probability distribution, the odds of NuVasive to move above current price in 30 days from now is about 51.13 (This NuVasive probability density function shows the probability of NuVasive Stock to fall within a particular range of prices over 30 days) .

NuVasive Top Holders

NuVasive Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Stephens Investment Management Group LlcCommon Shares621.4 K39.4 M
Assenagon Asset Management SaCommon Shares336.9 K21.4 M
First Hawaiian BankDebt96 K113 K
View NuVasive Diagnostics

NuVasive Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

NuVasive Key Fundamentals

NuVasive Against Markets

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

NuVasive Upcoming and Recent Events

NuVasive Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportOctober 30, 2019
Next Earnings ReportFebruary 19, 2020
Next Fiscal Quarter EndSeptember 30, 2019
Next Fiscal Year EndFebruary 19, 2020
Last Quarter Report DateJune 30, 2019
Last Earning Anouncement DateSeptember 30, 2018

NuVasive Corporate Filings

NuVasive Corporate Filings

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Financial Statements and Exhibits. Regulation FD Disclosure
Unclassified Corporate Event
Other Events

NuVasive Corporate Directors

Mike OHalleran Independent Director
Scott Huennekens Independent Director
Daniel Wolterman Director
Please see also Stocks Correlation. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.
Search macroaxis.com